跳至主要内容
临床试验/PACTR202312795734215
PACTR202312795734215尚未招募Unknown

A comparison of 150mg and 75mg aspirin for preventing preterm preeclampsia and associated fetal growth restriction amongst women at risk in Abuja: a randomised controlled study

Dr. Suraiya Auwal Suleiman0 个研究点目标入组 95 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
95

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • iPresence of one high risk factor for preeclampsia: Previous history of hypertensive disorders of pregnancy, autoimmune diseases (SLE and APS), chronic hypertension, diabetes mellitus.
  • iiPresence of two or more moderate risk factors for preeclampsia: =35 years, first pregnancy, nulliparity, BMI =30kg/m2, pregnancy interval >10 years, family history of preeclampsia, personal history (low birth weight or small for gestational age, and previous adverse pregnancy outcome).
  • iiiWillingness to be followed up until 37 weeks or occurrence of outcome.

排除标准

  • iHypersensitivity to aspirin
  • iiLong-term use of non-steroidal anti-inflammatory drugs (NSAID)
  • iiiAsthmatic patients
  • ivChronic liver or kidney disease
  • vBleeding disorders including peptic ulcer disease
  • viCigarette smoking, alcohol consumption or illicit drug use
  • viiMultifetal gestation
  • viiiFetal congenital anomalies

研究者

发起方
Dr. Suraiya Auwal Suleiman

相似试验

A comparison of 150mg and 75mg aspirin for... | 临床试验